CS204035B2 - Method of producing dihydrochloride monohydrate of racemic 3-/2-/3-tertiary butylamino-2-hydroxypropoxy/-phenyl/-6-hydrazinopyridazine - Google Patents
Method of producing dihydrochloride monohydrate of racemic 3-/2-/3-tertiary butylamino-2-hydroxypropoxy/-phenyl/-6-hydrazinopyridazine Download PDFInfo
- Publication number
- CS204035B2 CS204035B2 CS785723A CS572378A CS204035B2 CS 204035 B2 CS204035 B2 CS 204035B2 CS 785723 A CS785723 A CS 785723A CS 572378 A CS572378 A CS 572378A CS 204035 B2 CS204035 B2 CS 204035B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- dihydrochloride monohydrate
- water
- racemic
- phenyl
- hydrazinopyridazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7832312 | 1978-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS204035B2 true CS204035B2 (en) | 1981-03-31 |
Family
ID=10498866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS785723A CS204035B2 (en) | 1978-08-04 | 1978-09-04 | Method of producing dihydrochloride monohydrate of racemic 3-/2-/3-tertiary butylamino-2-hydroxypropoxy/-phenyl/-6-hydrazinopyridazine |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0007930B1 (bg) |
| JP (1) | JPS6040424B2 (bg) |
| AR (1) | AR223327A1 (bg) |
| AT (1) | AT361001B (bg) |
| BG (1) | BG34335A3 (bg) |
| CA (1) | CA1098522A (bg) |
| CS (1) | CS204035B2 (bg) |
| DD (1) | DD138656A5 (bg) |
| DE (1) | DE2862214D1 (bg) |
| DK (1) | DK147761C (bg) |
| EG (1) | EG13469A (bg) |
| ES (1) | ES473056A1 (bg) |
| FI (1) | FI64585C (bg) |
| GR (1) | GR64897B (bg) |
| HU (1) | HU181959B (bg) |
| IE (1) | IE47555B1 (bg) |
| IL (1) | IL55455A (bg) |
| IN (1) | IN148775B (bg) |
| IT (1) | IT1110169B (bg) |
| MT (1) | MTP851B (bg) |
| MX (1) | MX5425E (bg) |
| NO (1) | NO783005L (bg) |
| NZ (1) | NZ188281A (bg) |
| OA (1) | OA06046A (bg) |
| PL (1) | PL119444B1 (bg) |
| SU (1) | SU897110A3 (bg) |
| YU (1) | YU209078A (bg) |
| ZA (1) | ZA785008B (bg) |
| ZM (1) | ZM8078A1 (bg) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE42214B1 (en) * | 1974-06-18 | 1980-07-02 | Smith Kline French Lab | Hydrazinopyredazines |
-
1978
- 1978-08-21 IN IN619/DEL/78A patent/IN148775B/en unknown
- 1978-08-22 IE IE1702/78A patent/IE47555B1/en unknown
- 1978-08-28 GR GR57100A patent/GR64897B/el unknown
- 1978-08-28 NZ NZ188281A patent/NZ188281A/xx unknown
- 1978-08-29 JP JP53106180A patent/JPS6040424B2/ja not_active Expired
- 1978-08-29 IL IL55455A patent/IL55455A/xx unknown
- 1978-08-30 EG EG541/78A patent/EG13469A/xx active
- 1978-08-31 IT IT27234/78A patent/IT1110169B/it active
- 1978-09-01 ZA ZA00785008A patent/ZA785008B/xx unknown
- 1978-09-01 CA CA310,530A patent/CA1098522A/en not_active Expired
- 1978-09-01 HU HU78SI1646A patent/HU181959B/hu unknown
- 1978-09-04 YU YU02090/78A patent/YU209078A/xx unknown
- 1978-09-04 CS CS785723A patent/CS204035B2/cs unknown
- 1978-09-04 PL PL1978209407A patent/PL119444B1/pl unknown
- 1978-09-04 NO NO783005A patent/NO783005L/no unknown
- 1978-09-04 SU SU782660649A patent/SU897110A3/ru active
- 1978-09-04 OA OA56598A patent/OA06046A/xx unknown
- 1978-09-04 DD DD78207634A patent/DD138656A5/xx unknown
- 1978-09-04 DK DK389378A patent/DK147761C/da not_active IP Right Cessation
- 1978-09-04 FI FI782705A patent/FI64585C/fi not_active IP Right Cessation
- 1978-09-04 AT AT638378A patent/AT361001B/de not_active IP Right Cessation
- 1978-09-04 ES ES473056A patent/ES473056A1/es not_active Expired
- 1978-09-04 BG BG7840811A patent/BG34335A3/bg unknown
- 1978-09-04 DE DE7878300341T patent/DE2862214D1/de not_active Expired
- 1978-09-04 MX MX787372U patent/MX5425E/es unknown
- 1978-09-04 EP EP78300341A patent/EP0007930B1/en not_active Expired
- 1978-09-05 AR AR273573A patent/AR223327A1/es active
- 1978-09-15 ZM ZM80/78A patent/ZM8078A1/xx unknown
-
1979
- 1979-07-23 MT MT851A patent/MTP851B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5504216A (en) | Method for reparing an amorphous sulfonamide | |
| JP5086069B2 (ja) | 重硫酸アタザナビルおよび新規形態の製造方法 | |
| CZ293507B6 (cs) | Bisulfátová sůl HIV proteázového inhibitoru | |
| JP2007522172A (ja) | リン酸ロシグリタゾン及び多形体形態 | |
| JP2012518623A (ja) | Ｃｏｐｄの処置に有用な５−ピラゾリル−２−ピリドン誘導体のトシル酸塩 | |
| RU2125571C1 (ru) | СОЛЬ 7-([1α,5α,6α]-6-АМИНО-3-АЗАБИЦИКЛО [3.1.0] ГЕКС-3-ИЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНИЛ)-1,4- ДИГИДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЙ И МЕТАНСУЛЬФОНОВОЙ КИСЛОТ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ | |
| WO2020214921A1 (en) | Solid forms of modulators of cftr | |
| US6534505B2 (en) | Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same | |
| JP2023103328A (ja) | ビランテロールトリフェニル酢酸塩の新規な結晶形態及びこれらの調製プロセス | |
| US5739381A (en) | Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present | |
| CS204035B2 (en) | Method of producing dihydrochloride monohydrate of racemic 3-/2-/3-tertiary butylamino-2-hydroxypropoxy/-phenyl/-6-hydrazinopyridazine | |
| UA124073C2 (uk) | Кристалічні форми гідрохлориду складного бутилового ефіру 4-((r)-2-{[6-((s)-3-метоксипіролідин-1-іл)-2-фенілпіримідин-4-карбоніл]-аміно}-3-фосфонопропіоніл)-піперазин-1-карбонової кислоти | |
| DK158729B (da) | N-(3-trifluormethylphenyl)-n'-propargylpiperazin, farmaceutiske praeparater, der indeholder det, dets anvendelse, samt en fremgangsmaade til fremstilling af et farmaceutisk praeparat | |
| JPS61167674A (ja) | （１，２，４‐オキサジアゾール‐３‐イル）‐アリールメタノン類およびそれらの製造方法 | |
| WO2023181076A1 (en) | Process for preparation of pure sitagliptin and salts thereof | |
| CZ2018277A3 (cs) | Pevné formy Roxadustatu | |
| US3829572A (en) | Analgesic composition | |
| JPH01203381A (ja) | 変力剤の水和物 | |
| CZ2017125A3 (cs) | Pevné formy lesinuradu | |
| CZ240891A3 (en) | process of separating mixture of l-(-)- and dl-(+)-ephedrine with a high content of racemate |